Skip to main content

Table 1 Definition of limited antineoplastic treatment options

From: The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home

Disease

Limited treatment options

Breast cancer

Refractory to 3rd line antineoplastic treatment for metastatic disease

Lung cancer

Refractory to 1st line chemotherapy for metastatic/advanced disease

Gastrointestinal cancers

Refractory to 1st line chemotherapy for metastatic/advanced disease

Ovarian cancer/Uterine cancer

Refractory to 2nd line chemotherapy for metastatic/advanced disease

Cervical cancer/Vulva cancer

Refractory to 1st line chemotherapy for metastatic/advanced disease

CNS tumors

Refractory to concomitant/adjuvant chemotherapy

Prostate cancer/Bladder cancer/Penile cancer/Thyme cancer/Adrenal carcinomas

Refractory to 1st line chemotherapy for metastatic/advanced disease

Cancer of Unknown Primary origin (CUP)

Refractory to 1st line chemotherapy for metastatic/advanced disease

Head and neck cancer

Refractory to radiation therapy or surgery with curative intention